SAN MATEO, Calif., Dec. 8, 2015 /PRNewswire/ -- Maverix Biomics, Inc., a leading genomic analysis software company, and Diagnomics, a developer of innovative products and services for personalized ...

After two decades effecting change in commercial diagnostics, this achievement is the brightest spot of my career, with a profound culmination of scientific, clinical, and social impact," —Elizabeth ...

IRVINE, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel tests for the early diagnosis and management of lung cancer, today announced the ...

Company completes CLIA Validation of DetermaIO™, previously the Insight Genetics IM Score Test, establishing the test as a reliable and robust assay for identifying patients likely to respond to ...

FOSTER CITY, Calif., May 28, 2025 /PRNewswire/ -- 1Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful completion of a CLIA-grade ...